RE: Dracula29 Sep 2019 20:22
As I thought, no reply.
So looking forward as ever to the week coming, last week has gone, I fail to see where discussing the positives falls into ramping. I am fully aware of funding issues, trial data issues, that goes into my risk assesment for my investment, along with a few other issues too.
Personally I fail to believe nobody else has considered those, but we have a mmix here, those whose losses are higher and choose not to sell, those whose losses were higher and have averaged down courtesy of AIM, and believe we will go higher and those who enjoyed what I believe was a great entry price, who might have taken profits, (considerable) or who are on a free ride. Pretty sure there are other catagories. So you asked why we are at 7p if it is so great, well funny enough I addresed that and you haven"t mentioned it since, so please come up with something new, because personally I learnt from a few older posters who called this right as to timelines. So your opinion is valuable, personal vendettas because we defended this share on the VAL BB, are not.
Nothing we say on here will move this share, apart from a very few temporary movements, what interests me is who is building stakes. Many reasons to have a seller, just the one I can think of to have a buyer, and we do have a buyer. Vulpes interests me as does the appointment of Samantha Paston with the TCR developments, the third platform, SCIB1 trial, SCIB2 trial under CRUK, and the forthcoming MOD1 trial just to mention a few. So please come up with as many negatives and without getting personal we can discuss them? Goodnight
Sign In
Follow the stocks
